(66) including a total of 13 comparative studies is the most recent research on adjuvant therapies for UUTT. Ultimately, the authors emphasized the need for new therapeutic agents and more randomized clinical trials (66).
Seventeen percent of patients with UUT tumors (UUTTs) have concomitant bladder tumors (3).
In recurrences of UUTTs, 22-47% of tumors are detected in the bladder, and 26% in the UUT (10).
The nephrectomy portion of radical surgery for UUTTs has been standardized in terms of surgical principles, regardless of the technique used.